doi: 10.1111/j.1469-0691.2004.00878.x.
Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital
Affiliations
- PMID: 15113326
- DOI: 10.1111/j.1469-0691.2004.00878.x
Item in Clipboard
Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital
Clin Microbiol Infect.
2004 May.
Free article
Abstract
Staphylococcus aureus isolates were screened for reduced susceptibility to glycopeptides with an initial glycopeptide agar screening test, followed by confirmation of the strains thus identified by two Etest strip techniques and population analysis. This procedure detected 48 methicillin-resistant S. aureus (MRSA) isolates with reduced susceptibility to glycopeptides from 24 patients among 883 MRSA isolates tested. The dissemination of a single clone was confirmed by pulsed-field gel electrophoresis.
Similar articles
-
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.Clin Microbiol Infect. 2004 May;10(5):448-51. doi: 10.1111/j.1469-0691.2004.00830.x. Clin Microbiol Infect. 2004. PMID: 15113324
-
An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.Clin Infect Dis. 2000 Nov;31(5):1306-8. doi: 10.1086/317464. Clin Infect Dis. 2000. PMID: 11073773
-
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.Clin Microbiol Infect. 2005 Mar;11(3):214-20. doi: 10.1111/j.1469-0691.2004.01060.x. Clin Microbiol Infect. 2005. PMID: 15715719
-
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20. Int J Antimicrob Agents. 2007. PMID: 17888634 Review.
-
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592. Clin Infect Dis. 2008. PMID: 18462091 Review.
Cited by
-
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.J Clin Microbiol. 2007 Feb;45(2):329-32. doi: 10.1128/JCM.01508-06. Epub 2006 Nov 15. J Clin Microbiol. 2007. PMID: 17108069 Free PMC article.
-
Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients.BMC Microbiol. 2009 Sep 4;9:189. doi: 10.1186/1471-2180-9-189. BMC Microbiol. 2009. PMID: 19732456 Free PMC article.
-
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.Clin Microbiol Rev. 2010 Jan;23(1):99-139. doi: 10.1128/CMR.00042-09. Clin Microbiol Rev. 2010. PMID: 20065327 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
